BlackRock, Inc. 13D and 13G filings for Pacific Biosciences of California, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-24 5:23 pm Purchase | 2023-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 24,642,666 9.200% | 6,108,207 (+32.96%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 18,534,459 8.200% | 1,965,215 (+11.86%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 16,569,244 7.500% | 1,453,754 (+9.62%) | Filing |
| 2021-01-29 5:22 pm Purchase | 2020-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 15,115,490 8.100% | 3,082,170 (+25.61%) | Filing |
| 2020-02-10 07:32 am Purchase | 2019-12-31 | 13G | Pacific Biosciences of California, Inc. PACB | BlackRock Inc. BLK | 12,033,320 7.900% | 776,990 (+6.90%) | Filing |